Angola vs Eswatini: HIV-positive TB patients on ART (antiretroviral therapy)
Angola
99.0%
in 2024
Eswatini
99.0%
in 2024
Angola rank
57th
Eswatini rank
57th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Angola
- Eswatini
How they compare
Angola currently reports 99.0% against 99.0% in Eswatini, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2007 it was Eswatini ahead.
Angola ranks 57th and Eswatini ranks 57th of 144 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.2% | 22.5% | 11.2% | Eswatini |
| 2010s | 68.8% | 73.5% | 4.7% | Eswatini |
| 2020s | 80.4% | 98.0% | 17.6% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Angola or Eswatini?
- Angola, at 99.0% against 99.0% in Eswatini as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Angola and Eswatini?
- 0.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Eswatini?
- 13 years are reported by both, from 2007 to 2024.
- How do Angola and Eswatini rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Angola ranks 57th and Eswatini ranks 57th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.